Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07083583 · ClinicalTrials.gov registry record
Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders
A clinical trial of Bleeding and Iron, sponsored by Nicoletta C Machin.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT07083583 is a study of Bleeding and Iron that is actively recruiting participants, run by Nicoletta C Machin. The registered enrollment target is 40 participants, below the 1,483-participant average among 23 other Bleeding trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07083583, a study of Bleeding and Iron, is actively recruiting participants, sponsored by Nicoletta C Machin.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, single-arm, single-center observational study evaluating the impact of intravenous (IV) iron replacement in patients with inherited bleeding disorders and iron deficiency (ferritin \<50ng/dL). Subjects will undergo baseline bleeding assessments, quality-of-life measures, and laboratory tests before receiving standard-of-care IV iron. Follow-up blood work and questionnaires will be conducted post-replacement to assess for changes
Conditions Studied
Interventions
- DRUG IV Iron (standard of care)
Study Locations (1)
Pennsylvania
- Hemophilia Center of Western Pennsylvania - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-08-08 |
| Est. Completion | 2027-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07083583
The ClinicalTrials.gov registry entry for NCT07083583 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,483-participant average among 23 other Bleeding trials with a reported enrollment target (97% lower). The listed sponsor is Nicoletta C Machin, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Bleeding appearing as the primary indexed condition, and to 1 intervention - of which IV Iron (standard of care) is the first listed.
NCT07083583 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07083583 about?
NCT07083583 is a clinical study titled "Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders". This is a prospective, single-arm, single-center observational study evaluating the impact of intravenous (IV) iron replacement in patients with inherited bleeding disorders and iron deficiency (ferritin \<50ng/dL). Subjects will undergo baseline bleeding assessments, quality-of-life measures, and l...
What is the current status of trial NCT07083583?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-08-08. Estimated completion is 2027-10-01.
What conditions does trial NCT07083583 study?
This clinical trial studies the following conditions: Bleeding, Iron, Bleeding Disorders, Platelet.
What interventions are being tested in trial NCT07083583?
The interventions under investigation include: IV Iron (standard of care) (DRUG).
Who is sponsoring clinical trial NCT07083583?
This trial is sponsored by Nicoletta C Machin, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07083583 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bleeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
RECRUITING · Phase 2
-
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
RECRUITING
-
Quantra Point-of-Care Hemostasis Monitoring
RECRUITING · NA
-
Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device
RECRUITING · Phase 4
-
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
RECRUITING · Phase 3
-
Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.